Cantor Fitzgerald’s $28 target on PFE

PFE Pfizer

$28.3 → $28 (-1%) by Oct 2027

Neutral · raises · said Oct 10, 2026 · 12-month default horizon

Open: judged on the close on Oct 10, 2027

The article this target came from

Four Analysts Raised Their Pfizer Targets in One Week Without an Upgrade. Here’s Where the Stock Could Go By 2030

TIKR.com · Oct 10, 2026

JPMorgan moved to $30 from $28, and BofA to $29 from $27 and Cantor Fitzgerald to $28 from $27, all keeping Neutral ratings.

Cantor Fitzgerald’s track record → Pfizer →

A fact about what Cantor Fitzgerald published, as reported by TIKR.com, not a recommendation from Dalsna Finance; Cantor Fitzgerald is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.